Respiratory Syncytial Virus Therapeutics Market to Rise at a 14.6% CAGR from 2023 to 2031, Reaching a Value of USD 3.8 billion | Exclusive Report by Transparency Market Research, Inc.
13 févr. 2024 11h55 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The respiratory syncytial virus (RSV) therapeutics market was valued at US$ 1.1 billion in...